Page 3 - David Angulo News Today

Positive results were announced from a phase 3 study evaluating ibrexafungerp for the prevention of recurrent vulvovaginal candidiasis.

15.12.2021 - Orphan medicinal product designation will provide at least 10 years of market exclusivity in the EU for ibrexafungerp for invasive candidiasis. SCYNEXIS recently was awarded a new patent in the U.S. and obtained allowance of an additional ... Seite 1

SAN DIEGO — The District Attorney’s Office on Friday said it has cleared police officers involved in five unrelated shootings in San Diego County over the last year, four of which were fatal. Prosecutors found that officers had acted reasonably in the five shootings, which date back to July 2020. Guns — or objects that officers thought looked like guns — played a role in four of them. The fifth person was carrying a metal bar when he charged police. The District Attorney’s Office sa...

DA Office says 20 police officers in five shootings were not guilty San Diego (CNS)-The San Diego County District Attorney’s Office issued a report on Friday stating that 20 local police officers will not face criminal charges related to five shooting incidents involving police officers, four of which resulted in deaths. The report investigated in detail the July 2020 shooting incidents involving highway patrol personnel in San Diego, Chula Vista, and California. Two of the cases involved the...

San Diego DAs office clears 20 officers in five separate police shootings FILE and last updated 2021-07-02 21:34:36-04 SAN DIEGO (CNS) - The San Diego County District Attorneys Office released reports Friday indicating that 20 local police officers will not face criminal charges related to five separate officer-involved shootings, four of which resulted in fatalities. The reports detail investigations into shootings involving San Diego, Chula Vista and California Highway Patrol officers dating ...

What to know about the new yeast infection treatment, which works on strains of yeast that don't respond well to current medication.

Approval of BREXAFEMME represents the first approved drug in a novel antifungal class in more than 20 yearsBREXAFEMME, a one-day oral treatment for vaginal yeast infection, is the first... | June 2, 2021

Brexafemme's approval first in a novel antifungal class in more than 20 years

Regulators OK’d a new antifungal treatment, but critics say it is unneeded and costs too much.